|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,929.25 GBX | +1.03% |
|
-5.64% | +4.93% |
| 09:00am | GSK : JP Morgan gives a Sell rating | ZD |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 103B | |||||
| 1T | |||||
| 613B | |||||
| 433B | |||||
| 350B | |||||
| 292B |
- Stock Market
- Stocks
- GSK Stock
- Charts GSK plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
